Laila A. Hassan

Laila A. Hassan

Rheumatology

11914 Astoria Blvd
Ste 330
Houston, TX 77089

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Comparing immunogenicity and safety following transition from reference rituximab to biosimilar rituximab (DRL_RI) in patients with rheumatoid arthritis: a randomized, double-blind, phase 3 study.

Comparing immunogenicity and safety following transition from reference rituximab to biosimilar rituximab (DRL_RI) in patients with rheumatoid arthritis: a randomized, double-blind, phase 3 study.

Journal: Arthritis research & therapy

Published: July 09, 2024

Showing 1-1 of 1

Last Updated: 09/26/2026